Latest Regulatory News

Page 565 of 627
Auswide Bank’s acquisition by MyState Bank has reached a key milestone with the scheme of arrangement now legally effective, triggering a suspension of Auswide’s shares and setting the stage for shareholder transitions.
Victor Sage
Victor Sage
10 Feb 2025
Alterity Therapeutics has raised A$40 million through a two-tranche placement to advance its lead compound ATH434 for neurodegenerative diseases, including Multiple System Atrophy and Parkinson's disease.
Ada Torres
Ada Torres
10 Feb 2025
KALINA Power has significantly expanded its land holdings in Alberta, boosting its potential Power-CCS capacity to 1.7 GW to meet surging demand for data centre power solutions with carbon capture.
Maxwell Dee
Maxwell Dee
10 Feb 2025
WAM Global reports a robust 23.7% increase in its investment portfolio for the year ending December 2024, prompting a rise in fully franked dividends including a special payout. The company’s strong financial results underscore its confidence in sustained growth and shareholder returns.
Claire Turing
Claire Turing
10 Feb 2025
8VI Holdings Limited has requested an immediate voluntary suspension of its securities on the ASX, paving the way for its planned delisting on 13 February 2025.
Claire Turing
Claire Turing
10 Feb 2025
Wellnex Life Limited has announced a non-renounceable entitlement offer to raise approximately $22.1 million at $0.65 per share, supporting its planned AIM listing and strategic growth initiatives.
Victor Sage
Victor Sage
10 Feb 2025
Arovella Therapeutics has requested a voluntary suspension of its ASX-listed securities pending a material announcement on a capital raising, expected by 17 February 2025.
Ada Torres
Ada Torres
10 Feb 2025
Wellnex Life Limited has initiated a $22.1 million entitlement offer priced at $0.65 per share, coinciding with its proposed dual listing on the London Stock Exchange's AIM market, driven by strong UK institutional interest.
Ada Torres
Ada Torres
10 Feb 2025
BTC Health has transformed its decade-long license agreement with Arna Pharma into an indefinite partnership, gaining royalties from Singapore and Malaysia sales and first rights to new pharmaceutical products in Australia and New Zealand.
Ada Torres
Ada Torres
10 Feb 2025
S2 Resources has initiated its first aircore drilling campaign at the Yeungroon project, aiming to delineate gold-arsenic hotspots along the extensive O'Connors trend. Results are expected by April 2025, potentially unlocking new opportunities in Victoria’s historic goldfields.
Maxwell Dee
Maxwell Dee
10 Feb 2025
Scorpion Minerals Limited has voluntarily suspended trading of its shares as it finalises a capital raising and a potential joint venture agreement, signaling significant corporate developments ahead.
Maxwell Dee
Maxwell Dee
10 Feb 2025
BlinkLab has secured North Shore Pediatric Therapy as the second US clinical site in its autism diagnostic study, enhancing recruitment and data quality with a leading Chicago-based specialist.
Ada Torres
Ada Torres
10 Feb 2025